Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders

  1. Alvaro Rada-Iglesias1,5,6,
  2. Adam Ameur2,5,
  3. Philipp Kapranov3,
  4. Stefan Enroth2,
  5. Jan Komorowski2,4,
  6. Thomas R. Gingeras3, and
  7. Claes Wadelius1,7
  1. 1 Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-75185 Uppsala, Sweden;
  2. 2 Linnaeus Centre for Bioinformatics, Uppsala University, SE-75185 Uppsala, Sweden;
  3. 3 Affymetrix, Inc., Santa Clara, California 95051, USA;
  4. 4 Interdisciplinary Centre for Mathematical and Computational Modelling, Warsaw University, 02-106 Warsaw, Poland
  1. 5 These authors contributed equally to this work.

Abstract

Transcription factors and histone modifications are crucial regulators of gene expression that mutually influence each other. We present the DNA binding profiles of upstream stimulatory factors 1 and 2 (USF1, USF2) and acetylated histone H3 (H3ac) in a liver cell line for the whole human genome using ChIP-chip at a resolution of 35 base pairs. We determined that these three proteins bind mostly in proximity of protein coding genes transcription start sites (TSSs), and their bindings are positively correlated with gene expression levels. Based on the spatial and functional relationship between USFs and H3ac at protein coding gene promoters, we found similar promoter architecture for known genes and the novel and less-characterized transcripts human mRNAs and spliced ESTs. Furthermore, our analysis revealed a previously underestimated abundance of genes in a bidirectional conformation, where USFs are bound in between TSSs. After taking into account this promoter conformation, the results indicate that H3ac is mainly located downstream of TSS, and it is at this genomic location where it positively correlates with gene expression. Finally, USF1, which is associated to familial combined hyperlipidemia, was found to bind and potentially regulate nuclear mitochondrial genes as well as genes for lipid and cholesterol metabolism, frequently in collaboration with GA binding protein transcription factor alpha (GABPA, nuclear respiratory factor 2 [NRF-2]). This expands our understanding about the transcriptional control of metabolic processes and its alteration in metabolic disorders.

Footnotes

  • 6 Present address: Endocrinology Unit, Hospital Clinic, Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona 08036, Spain.

  • 7 Corresponding author.

    7 E-MAIL Claes.Wadelius{at}genpat.uu.se; fax 46-18-4714808.

  • [Supplemental material is available online at www.genome.org. The microarray data from this study have been submitted to ArrayExpress under accession no. E-TABM-314.]

  • Article published online before print. Article and publication date are online at http://www.genome.org/cgi/doi/10.1101/gr.6880908

    • Received July 4, 2007.
    • Accepted December 11, 2007.
| Table of Contents